PNC Financial Services Group’s Perspective Therapeutics CATX Stock Holding History

PNC Financial Services Group’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$750	Sell	220 -1	-0.5%	-$4	﹤0.01%	4899
2026 Q1	$922	Buy	221 +145	+191%	+$613	﹤0.01%	4776
2025 Q4	$209	Sell	76 -1,108	-94%	-$3.16K	﹤0.01%	4974
2025 Q3	$4.06K	Sell	1,184 -649	-35%	-$2.37K	﹤0.01%	4293
2025 Q2	$6.3K	Buy	+1,833	New	+$4.84K	﹤0.01%	4039
2017 Q4	–	Sell	-2,000	Closed	-$10K	–	4146
2017 Q3	$10K	Hold	2,000	–	–	﹤0.01%	3671
2017 Q2	$13K	Hold	2,000	–	–	﹤0.01%	3485
2017 Q1	$12K	Hold	2,000	–	–	﹤0.01%	3462
2016 Q4	$12K	Hold	2,000	–	–	﹤0.01%	3413
2016 Q3	$14K	Hold	2,000	–	–	﹤0.01%	3369
2016 Q2	$17K	Hold	2,000	–	–	﹤0.01%	3336
2016 Q1	$18K	Hold	2,000	–	–	﹤0.01%	3318
2015 Q4	$19K	Hold	2,000	–	–	﹤0.01%	3320
2015 Q3	$28K	Hold	2,000	–	–	﹤0.01%	3191
2015 Q2	$30K	Hold	2,000	–	–	﹤0.01%	3294
2015 Q1	$31K	Hold	2,000	–	–	﹤0.01%	3281
2014 Q4	$29K	Hold	2,000	–	–	﹤0.01%	3008
2014 Q3	$34K	Buy	+2,000	New	+$49.5K	﹤0.01%	2852

Other funds holding CATX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

PNC Financial Services Group's CATX Position: Q2 2026 in Review

PNC Financial Services Group reduced its Perspective Therapeutics (CATX) stake by 0.45% in Q2 2026, selling an estimated $4 and leaving 220 shares worth $750. The position accounts for ﹤0.01% of the portfolio, ranked #4899.

PNC Financial Services Group first reported a position in CATX in Q3 2014 and has held it in 18 quarters since. The position peaked at $34K in Q3 2014. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

PNC Financial Services Group held 220 shares of Perspective Therapeutics worth $750 as of Q2 2026.
PNC Financial Services Group sold 1 Perspective Therapeutics share in Q2 2026, an estimated $4.
Perspective Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4899 holding.
PNC Financial Services Group first reported a position in Perspective Therapeutics in Q3 2014 and has held it in 18 quarters since.
PNC Financial Services Group's Perspective Therapeutics position peaked at $34K in Q3 2014.
132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.